Value Dossier Icon

Transition to EU HTA – Consequences of an existence of national and EU HTA in parallel

Overview of our services Strategic advice   Regulation (EU) 2021/2282 Article 7 (1) of Regulation (EU) 2021/2282 specifies when a health technology must undergo a Joint Clinical Assessment (JCA). Paragraph 1a stipulates that the time of initial market authorization application (MAA) is decisive. A JCA of the new health technology only needs to be

2024-04-19T12:58:28+02:0019. February 2024|European HTA|0 Comments

GKV-FinStG draft law: Power shift in favor of the statutory health insurance companies expected

The German Federal Ministry of Health has published a draft law on the financial stabilization of the statutory health insurance (GKV-FinStG). The subjects of the draft are amendments to the Social Code Book V, in particular Articles § 35 a and § 130 b, which include the early benefit assessment of new active substances and

Go to Top